An Uncontrolled, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
ENSAYO CLINICO COMERCIAL
Información del ensayo clínico
- Promotor: BIOGEN IDEC LIMITED
- Fase: II
- Comienzo de la ejecución: 08/11/2017
- Fin de la ejecución: 30/04/2019
- IP: RAFAEL GALVEZ MATEOS